KTTA - Pasithea Therapeutics Corp
0.7965
0.006 0.816%
Share volume: 82,290
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$0.79
0.01
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-13-2024 | 11-13-2024 | 03-24-2025 | 05-15-2025 | 11-13-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | ||||
| Operating expenses | 4.041 M | 3.945 M | 3.005 M | 3.260 M | 3.680 M | 3.110 M | |
| Selling general and admin | 2.292 M | 1.587 M | 1.423 M | 1.750 M | 1.950 M | 1.752 M | |
| Research and development | 1.749 M | 2.358 M | 1.581 M | 1.510 M | 1.730 M | 1.358 M | |
| Total expenses | 4.041 M | 3.945 M | 3.005 M | 3.260 M | 3.680 M | 3.110 M | |
| -2.37% | -23.84% | 8.49% | 12.90% | -15.49% | |||
| Operating income | -4.041 M | -3.945 M | -3.005 M | -3.260 M | -3.680 M | -3.110 M | |
| Ebit | -3.861 M | -3.866 M | -3.070 M | -3.531 M | -3.610 M | -3.081 M | |
| Pretax income | -3.861 M | -3.866 M | -3.000 M | -3.178 M | -3.563 M | -3.037 M | |
| 0.14% | -22.41% | 5.93% | 12.13% | -14.76% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -3.861 M | -3.866 M | -3.000 M | -3.178 M | -3.563 M | -3.037 M | |
| -0.14% | 22.41% | -5.93% | -12.13% | 14.76% |